Author

Shreya Lal

Observed name: Lal Shreya

Institutions: Emcure Pharmaceuticals (India), Fortis Escorts Heart Institute, Sir Ganga Ram Hospital

Observed institutions: Rajendra Institute of Medical Sciences, Emcure Pharmaceuticals (India), Fortis Escorts Heart Institute, Sir Ganga Ram Hospital

ORCID: 0000-0001-6905-4902

Observed ORCID: 0000-0001-6905-4902

OpenAlex ID: A5006553207

Comparative Study to Assess the Effectiveness of Topical Nifedipine and Diltiazem in the Treatment of Chronic Anal Fissure

2020 · Archana Dipa Sangita Kujur, Nishith M. Paul Ekka, et al. · Journal of Family Medicine and Primary Care · 22

Frequency of iron deficiency anemia in type 2 diabetes - Insights from tertiary diabetes care centres across India

2022 · Rajendra Pradeepa, Lal Shreya, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 21

Sex-Based Differences in Clinical Profile and Complications among Individuals with Type 2 Diabetes Seen at a Private Tertiary Diabetes Care Centre in India

2023 · Rajendra Pradeepa, Lal Shreya, et al. · Healthcare · 10

Evaluation of prescribing pattern of antidiabetic drugs in medicine outpatient clinic of a tertiary care teaching hospital

2017 · Vineet Kumar, Manmeet Topno, et al. · International Journal of Basic & Clinical Pharmacology · 2

Angiotensin Receptor-Neprilysin Inhibitor Therapy and Cardiac Remodeling in Heart Failure: Consensus Statement from India

2023 · H K Chopra, G S Wande, et al. · Journal of the Association of Physicians of India

An Effectiveness, Safety and Tolerability Study of Azilsartan and Telmisartan in Patients of Essential Hypertension : a Randomized and Open-label Study

2020 · Shreya Lal, Satish Chandra, et al. · Journal of Biomedical and Pharmaceutical Research

Prescription auditing and observational study in a tertiary care hospital

2019 · Manju Gari, Manisha Varshney, et al. · International Journal of Basic & Clinical Pharmacology

Works count: 7

Citation count: 55

H-index: 3

I10-index: 3